Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
PLoS One ; 16(12): e0260006, 2021.
Article in English | MEDLINE | ID: covidwho-1581786

ABSTRACT

BACKGROUND: During the early COVID-19 pandemic travel in Uganda was tightly restricted which affected demand for and access to care for pregnant women and small and sick newborns. In this study we describe changes to neonatal outcomes in one rural central Ugandan newborn unit before and during the early phase of the COVID-19 pandemic. METHODS: We report outcomes from admissions captured in an electronic dataset of a well-established newborn unit before (September 2019 to March 2020) and during the early COVID-19 period (April-September 2020) as well as two seasonally matched periods one year prior. We report excess mortality as the percent change in mortality over what was expected based on seasonal trends. FINDINGS: The study included 2,494 patients, 567 of whom were admitted during the early COVID-19 period. During the pandemic admissions decreased by 14%. Patients born outside the facility were older on admission than previously (median 1 day of age vs. admission on the day of birth). There was an increase in admissions with birth asphyxia (22% vs. 15% of patients). Mortality was higher during COVID-19 than previously [16% vs. 11%, p = 0.017]. Patients born outside the facility had a relative increase of 55% above seasonal expected mortality (21% vs. 14%, p = 0.028). During this period patients had decreased antenatal care, restricted transport and difficulty with expenses and support. The hospital had difficulty with maternity staffing and supplies. There was significant community and staff fear of COVID-19. INTERPRETATION: Increased newborn mortality during the early COVID-19 pandemic at this facility was likely attributed to disruptions affecting maternal and newborn demand for, access to and quality of perinatal healthcare. Lockdown conditions and restrictions to public transit were significant barriers to maternal and newborn wellbeing, and require further focus by national and regional health officials.


Subject(s)
COVID-19/epidemiology , Hospitals, Rural/statistics & numerical data , Infant Mortality , Adult , Continuous Positive Airway Pressure/methods , Female , Hospitals, Rural/organization & administration , Humans , Infant , Infant, Newborn , Intensive Care Units, Neonatal/organization & administration , Intensive Care Units, Neonatal/statistics & numerical data , Maternal Age , Patient Admission/statistics & numerical data , Pregnancy , Retrospective Studies , Rural Health/statistics & numerical data , Uganda/epidemiology , Young Adult
2.
Rural Remote Health ; 21(3): 6464, 2021 07.
Article in English | MEDLINE | ID: covidwho-1308598

ABSTRACT

INTRODUCTION: Many rural hospitals and health systems in the USA lack sufficient resources to treat COVID-19. St Lawrence Health (SLH) developed a system for managing inpatient COVID-19 hospital admissions in St Lawrence County, an underserved rural county that is the largest county in New York State. METHODS: SLH used a hub-and-spoke system to route COVID-19 patients to its flagship hospital. It further assembled a small clinical team to manage admitted COVID-19 patients and to stay abreast of a quickly changing body of literature and standard of care. A review of clinical data was completed for patients who were treated by SLH's inpatient COVID-19 treatment team between 20 March and 22 May 2020. RESULTS: Twenty COVID-19 patients were identified. Sixteen patients (80%) met National Institutes of Health criteria for severe or critical disease. One patient died. No patients were transferred to other hospitals. CONCLUSION: During the first 2 months of the pandemic, the authors were able to manage hospitalized COVID-19 patients in their rural community. Development of similar treatment models in other rural areas should be considered.


Subject(s)
COVID-19 Drug Treatment , Health Services Accessibility/organization & administration , Rural Health/statistics & numerical data , Rural Population/statistics & numerical data , COVID-19/therapy , Female , Hospitals, Rural/organization & administration , Humans , Male , New York
4.
J Cancer Res Ther ; 17(2): 551-555, 2021.
Article in English | MEDLINE | ID: covidwho-1268377

ABSTRACT

BACKGROUND: The coronavirus disease 2019 (COVID 19) is a zoonotic viral infection that originated in Wuhan, China, in December 2019. It was declared a pandemic by the World Health Organization shortly thereafter. This pandemic is going to have a lasting impact on the functioning of pathology laboratories due to the frequent handling of potentially infectious samples by the laboratory personnel. To deal with this unprecedented situation, various national and international guidelines have been put forward outlining the precautions to be taken during sample processing from a potentially infectious patient. PURPOSE: Most of these guidelines are centered around laboratories that are a part of designated COVID 19 hospitals. However, proper protocols need to be in place in all laboratories, irrespective of whether they are a part of COVID 19 hospital or not as this would greatly reduce the risk of exposure of laboratory/hospital personnel. As part of a laboratory associated with a rural cancer hospital which is not a dedicated COVID 19 hospital, we aim to present our institute's experience in handling pathology specimens during the COVID 19 era. CONCLUSION: We hope this will address the concerns of small to medium sized laboratories and help them build an effective strategy required for protecting the laboratory personnel from risk of exposure and also ensure smooth and optimum functioning of the laboratory services.


Subject(s)
COVID-19/diagnosis , Clinical Laboratory Services/organization & administration , Infection Control/organization & administration , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Tertiary Care Centers/organization & administration , COVID-19/epidemiology , COVID-19/transmission , COVID-19/virology , Cancer Care Facilities/organization & administration , Cancer Care Facilities/standards , Clinical Laboratory Services/standards , Decontamination/methods , Decontamination/standards , Developing Countries , Disinfection/methods , Disinfection/organization & administration , Disinfection/standards , Hospitals, Rural/organization & administration , Hospitals, Rural/standards , Humans , India/epidemiology , Infection Control/standards , Medical Laboratory Personnel/organization & administration , Medical Laboratory Personnel/standards , Pandemics/prevention & control , SARS-CoV-2/isolation & purification , SARS-CoV-2/pathogenicity , Specimen Handling/standards , Tertiary Care Centers/standards , Workforce/organization & administration , Workforce/standards
5.
Adv Emerg Nurs J ; 43(2): 114-122, 2021.
Article in English | MEDLINE | ID: covidwho-1207365

ABSTRACT

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), also known as COVID-19, has rapidly spread across the globe resulting in a worldwide pandemic. This disease has such varying presentation within the population. Although rare, multisystem inflammatory syndrome in children (MIS-C) is a potentially fatal complication of SARS-CoV2 infection and can be easily missed in the early stages. Because emergency department (ED) providers are often the initial treating providers, knowledge of the clinical manifestations and treatment of MIS-C is essential. The purpose of this article is to present a case of MIS-C in a rural ED, describe the subtle signs of disease, and educate clinicians on this rare and potentially deadly disease.


Subject(s)
COVID-19/complications , Emergency Service, Hospital/organization & administration , Hospitals, Rural/organization & administration , Systemic Inflammatory Response Syndrome/etiology , COVID-19/etiology , COVID-19/virology , Child , Humans , Male , SARS-CoV-2/isolation & purification , Systemic Inflammatory Response Syndrome/drug therapy , Treatment Outcome , COVID-19 Drug Treatment
7.
Healthc (Amst) ; 9(2): 100508, 2021 Jun.
Article in English | MEDLINE | ID: covidwho-1062369

ABSTRACT

Research and media reports about coronavirus disease 2019 (COVID-19) have largely focused on urban areas due to their high caseloads. However, the COVID-19 pandemic presents distinct and under-recognized challenges to rural areas. This report describes the challenges faced by Bassett Healthcare Network (BHN), a health network in rural upstate New York, and the strategies BHN devised in response. The response to COVID-19 at BHN focused on 4 strategies: (1) Expansion of intensive-care capacity. (2) Redeployment and retraining of workforce. (3) Provision of COVID-19 information, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral testing, and appropriate follow-up for a geographically dispersed population. (4) Coordination of the response to the pandemic across a large, diverse organization. Rural health systems and hospitals can take steps to address the specific challenges posed by the COVID-19 pandemic in their communities. We believe that the strategies BHN employed to adapt to COVID-19 may be useful to other rural health systems. More research is needed to determine which strategies have been most effective in responding to the pandemic in other rural settings.


Subject(s)
COVID-19/epidemiology , Communicable Disease Control/organization & administration , Hospitals, Rural/organization & administration , Rural Health , Hospital Planning , Humans , New York/epidemiology , Pandemics , SARS-CoV-2 , Telemedicine
12.
Am Surg ; 87(8): 1214-1222, 2021 Aug.
Article in English | MEDLINE | ID: covidwho-992192

ABSTRACT

Rural surgeons from disparate areas of the United States report on the effects of the COVID-19 pandemic in their communities as the virus has spread across the country. The pandemic has brought significant changes to the professional, economic, and social lives of the individual surgeons and their communities.


Subject(s)
COVID-19/epidemiology , Rural Health Services , Surgeons , Alaska/epidemiology , Arizona/epidemiology , Health Services, Indigenous/organization & administration , Health Services, Indigenous/statistics & numerical data , Hospitals, Rural/organization & administration , Hospitals, Rural/statistics & numerical data , Humans , Idaho/epidemiology , Illinois/epidemiology , Indiana/epidemiology , Ohio/epidemiology , Oregon/epidemiology , Rural Health Services/organization & administration , Rural Health Services/statistics & numerical data , Rural Population , West Virginia/epidemiology
14.
Am Surg ; 86(6): 602-610, 2020 Jun.
Article in English | MEDLINE | ID: covidwho-657736

ABSTRACT

Nine surgeons from rural and remote communities in the United States share early experiences preparing for the COVID-19 pandemic. Relating experiences remarkably different from health care providers in urban areas in America most affected by the first stages of the outbreak, they tell the challenges of organizing resources in facilities already struggling with poverty-stricken communities far from established health care resources and supplies. From Alaska to Appalachia and the Navajo Nation to the rural midwest, they show the leadership and professionalism that exemplify rural surgery.


Subject(s)
Coronavirus Infections/epidemiology , Hospitals, Rural/organization & administration , Leadership , Pandemics , Pneumonia, Viral/epidemiology , Rural Health , Surgeons , Betacoronavirus , COVID-19 , Clinical Protocols , Coronavirus Infections/psychology , Hospitals, Rural/standards , Humans , Personal Protective Equipment/supply & distribution , Pneumonia, Viral/psychology , Poverty , SARS-CoV-2 , Social Isolation , Stress, Psychological , Surgeons/psychology , United States/epidemiology
15.
J Rural Health ; 36(4): 584-590, 2020 09.
Article in English | MEDLINE | ID: covidwho-624889

ABSTRACT

PURPOSE: During the COVID-19 epidemic, it is critical to understand how the need for hospital care in rural areas aligns with the capacity across states. METHODS: We analyzed data from the 2018 Behavioral Risk Factor Surveillance System to estimate the number of adults who have an elevated risk of serious illness if they are infected with coronavirus in metropolitan, micropolitan, and rural areas for each state. Study data included 430,949 survey responses representing over 255.2 million noninstitutionalized US adults. For data on hospital beds, aggregate survey data were linked to data from the 2017 Area Health Resource Files by state and metropolitan status. FINDINGS: About 50% of rural residents are at high risk for hospitalization and serious illness if they are infected with COVID-19, compared to 46.9% and 40.0% in micropolitan and metropolitan areas, respectively. In 19 states, more than 50% of rural populations are at high risk for serious illness if infected. Rural residents will generate an estimated 10% more hospitalizations for COVID-19 per capita than urban residents given equal infection rates. CONCLUSION: More than half of rural residents are at increased risk of hospitalization and death if infected with COVID-19. Experts expect COVID-19 burden to outpace hospital capacity across the country, and rural areas are no exception. Policy makers need to consider supply chain modifications, regulatory changes, and financial assistance policies to assist rural communities in caring for people affected by COVID-19.


Subject(s)
Betacoronavirus , Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Rural Health Services/statistics & numerical data , Rural Population/statistics & numerical data , Severity of Illness Index , Adult , COVID-19 , Female , Hospitals, Rural/organization & administration , Humans , Male , Pandemics , SARS-CoV-2 , United States
16.
J Rural Health ; 36(4): 577-583, 2020 09.
Article in English | MEDLINE | ID: covidwho-628472

ABSTRACT

BACKGROUND: Telehealth is likely to play a crucial role in treating COVID-19 patients. However, not all US hospitals possess telehealth capabilities. This brief report was designed to explore US hospitals' readiness with respect to telehealth availability. We hope to gain deeper insight into the factors affecting possession of these valuable capabilities, and how this varies between rural and urban areas. METHODS: Based on 2017 data from the American Hospital Association survey, Area Health Resource Files and Medicare cost reports, we used logistic regression models to identify predictors of telehealth and eICU capabilities in US hospitals. RESULTS: We found that larger hospitals (OR(telehealth) = 1.013; P < .01) and system members (OR(telehealth) = 1.55; P < .01) (OR(eICU) = 1.65; P < .01) had higher odds of possessing telehealth and eICU capabilities. We also found evidence suggesting that telehealth and eICU capabilities are concentrated in particular regions; the West North Central region was the most likely to possess capabilities, given that these hospitals had higher odds of possessing telehealth (OR = 1.49; P < .10) and eICU capabilities (OR = 2.15; P < .05). Rural hospitals had higher odds of possessing telehealth capabilities as compared to their urban counterparts, although this relationship was marginally significant (OR = 1.34, P < .10). CONCLUSIONS: US hospitals vary in their preparation to use telehealth to aid in the COVID-19 battle, among other issues. Hospitals' odds of possessing the capability to provide such services vary largely by region; overall, rural hospitals have more widespread telehealth capabilities than urban hospitals. There is still great potential to expand these capabilities further, especially in areas that have been hard hit by COVID-19.


Subject(s)
Coronavirus Infections/therapy , Health Services Accessibility/organization & administration , Hospitals, Rural/organization & administration , Pneumonia, Viral/therapy , Rural Population/statistics & numerical data , Telemedicine/statistics & numerical data , Attitude of Health Personnel , Betacoronavirus , COVID-19 , Coronavirus Infections/epidemiology , Electronic Health Records/organization & administration , Humans , Pandemics , Pneumonia, Viral/epidemiology , Rural Health Services/organization & administration , SARS-CoV-2 , United States
SELECTION OF CITATIONS
SEARCH DETAIL